Vectormune ND

Country: European Union

Language: Danish

Source: EMA (European Medicines Agency)

Active ingredient:

celleassocieret levende rekombinant kalkunherpesvirus (rHVT / ND), der udtrykker fusionsproteinet af Newcastle disease-virus-D-26-lentogen stamme

Available from:

CEVA-Phylaxia Co. Ltd.

ATC code:

QI01AD

INN (International Name):

Newcastle disease and Marek’s disease vaccine (live recombinant)

Therapeutic group:

Chicken; Embryonated eggs

Therapeutic area:

Immunologicals for aves, Live viral vacciner

Therapeutic indications:

Til aktiv immunisering af 18 dage gamle befrugtede æg eller en-dage gamle kyllinger til at reducere dødelighed og kliniske tegn forårsaget af Newcastle disease virus og til at reducere dødeligheden, kliniske tegn og læsioner forårsaget af Marek ' s disease virus med en fænotype, der er "fremme i skoene".

Product summary:

Revision: 7

Authorization status:

autoriseret

Authorization date:

2015-09-08

Patient Information leaflet

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Opdateret information om dette lægemiddel til dyr er tilgængelig på
webstedet for information om
lægemidler til dyr.

Summary of Product characteristics

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Opdateret information om dette lægemiddel til dyr er tilgængelig på
webstedet for information om
lægemidler til dyr.